focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SkinBio launches food supplement on Amazon

Thu, 30th Nov 2023 14:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Iofina PLC - Colorado, US-based manufacturing company that specialises in the production of iodine and the manufacture of speciality chemical derivatives - Reminds investors that the ramp-up of IO9, its iodine plant in Western Oklahoma, took longer than expected. Says that recent upgrades have improved the flow of brine water to the plant, adding that it has been able to steadily increase crystalline iodine production following the completion of this work. Confirms that the plant is now operating within its expected output range. Expects second-half production at the bottom, or very marginally below, the bottom end of the forecast range of 325 to 350 metric tonnes.

----------

SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Says that its AxisBiotix-Ps food supplement will launch on Amazon.co.uk from December 6. AxisBiotix-Ps is designed to help alleviate sensitive skin conditions like psoriasis. SkinBio Therapeutics says the sale of the product on Amazon is a key part of its commercialisation strategy, and that it aims to extend product availability through other Amazon country sites. Says management is already proactively seeking to expand online sales of AxisBiotix-Ps into France, Italy, and Spain, where the product has regulatory clearance.

----------

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Notes strategic progress towards end of first quarter, including contracts signed for four new projects, with additional contracts approved by customers and due to be signed in the second quarter. Says three of the contracts are with major pharmaceutical companies who were existing customers, while the fourth is with a new customer focused on "high throughput drug discovery". Chief Executive Officer Martin Gouldstone says: "I am encouraged to see the commercial traction already being made on delivering our strategy, including our ability to expand the application of our ImmunoINSIGHTS platform into drug discovery as well as clinical trials. I have recently spent time discussing our strategy with some of our key stakeholders and have been pleased to see how well it has been received, also allowing us to recruit top talent to further accelerate our ability to deliver on it."

----------

Baron Oil PLC - London-based oil & gas exploration and appraisal company - Celebrates as its wholly-owned owned subsidiary, SundaGas Banda Unipessoal Lda, gets project classification from Autoridade Nacional do Petroleo for the Chuditch field. Sundagas is the operator of the TL-SO-19-16 production sharing contract, offshore Timor-Leste, while ANP is the Timor-Leste government regulator for oil and gas. The next step is the submission of a term of reference, including initial public consultations. Baron Oil adds that, regarding drilling, a Timorese drilling engineer has been recruited to join the SundaGas well operations team, and expressions of interest are being sought from in-country suppliers to provide services from the Timorese private sector. It also continues to evaluate all potential options for gas export from the Chuditch field in order to be able to fast track the concept selection processes.

----------

Arkle Resources PLC - Exploration company, with principal assets in Irish gold and zinc exploration licences - Says a drilling programme at Inishowen in County Donegal is due to begin this week. The drilling, which is a follow-up to work at the Meeneragh target, will test the main gold bearing outcrop. Four holes are planned in this phase from two drill pads drilling at minus 45 and minus 70 degrees. The focus of the programme will be on the main vein target discovered earlier. Chair John Teeling says: "It is good to get back on the ground again at Inishowen. This new round of drilling will test to see if we can trace the main vein along strike and at depth. We found high grade gold in the area and we now aim to expand this."

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Sep 2018 11:43

Oncimmune Appoints Adam Hill As New Boss, Founder Becomes Vice Chair

LONDON (Alliance News) - Oncimmune Holdings PLC said Monday it appointed Adam Hill as its new boss as current Chief Executive Officer Geoffrey Hamilton-Fairley prepares to move to vice-chairman -

Read more
27 Mar 2018 13:34

Oncimmune Gets Final GBP3 Million Genostics Investment After Deal (ALLISS)

LONDON (Alliance News) - Oncimmune Holdings PLC said Tuesday it has received the final GBP3.0 million tranche of a GBP10.0 million investment Co

Read more
7 Nov 2016 15:17

Revenue shrinks and costs rise at Oncimmune

(ShareCast News) - Early cancer detection company Oncimmune Holdings announced its full year results for the year to 31 May on Monday, including £12.2m raised by the issue of equity in the year. The firm also said £4.2m of convertible loan notes were converted. Revenues for the year were down signi

Read more
22 Sep 2016 09:01

Oncimmune Notes Asia Focus With Chief Commercial Officer Appointment

Read more
17 Aug 2016 07:23

Oncimmune Makes Acting CFO Millet Permanent Finance Chief

Read more
15 Jul 2016 16:17

Oncimmune secures CE mark for EarlyCDT-Lung

(ShareCast News) - Early cancer detection technology company Oncimmune Holdings announced on Friday that it has obtained the CE mark for the reagents used in its EarlyCDT-Lung product - an autoantibody blood test that can detect cancer up to four years earlier than other methods. The AIM-traded firm

Read more
15 Jul 2016 07:55

Oncimmune Secures European CE Mark For Product EarlyCDT-Lung

Read more
4 Jul 2016 07:26

Oncimmune Signs Research Agreements To Further Validate EarlyCDT Tests

Read more
6 Jun 2016 16:44

Oncimmunce Holdings CFO Robert Page dies

(ShareCast News) - Robert Page, director and CFO of Oncimmune Holdings, has died unexpectedly from natural causes. Oncimmune Holdings, an early cancer detection and technology company, said Page died on Friday morning. Page became CFO in 2005 after holding a series of finance roles at telecommunica

Read more
6 Jun 2016 13:21

Oncimmune Holdings Says Chief Financial Officer Robert Page Has Died

Read more
25 May 2016 07:58

Oncimmune Signs Three New Distribution Deals In US

Read more
18 May 2016 08:46

Oncimmune Starts Trading On AIM As Motorpoint Shares Stay Firm (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.